Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.
Read More…
Industry, Sector and Symbol
Industry Home health care services
Sub-IndustryN/A
SectorMedical
Phone469-535-8200
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$518.12 million
Profitability
Miscellaneous
Employees33,153
Next Earnings Date11/4/2019 (Estimated)
OptionableOptionable
Addus Homecare (NASDAQ:ADUS) Frequently Asked Questions
What is Addus Homecare's stock symbol?
Addus Homecare trades on the NASDAQ under the ticker symbol "ADUS."
How were Addus Homecare's earnings last quarter?
Addus Homecare Co. (NASDAQ:ADUS) announced its quarterly earnings data on Monday, August, 5th. The company reported $0.47 earnings per share for the quarter, meeting the Thomson Reuters' consensus estimate of $0.47. The business earned $149.69 million during the quarter, compared to analyst estimates of $146.66 million. Addus Homecare had a return on equity of 8.55% and a net margin of 3.31%. View Addus Homecare's Earnings History.
When is Addus Homecare's next earnings date?
What price target have analysts set for ADUS?
7 Wall Street analysts have issued 1 year price objectives for Addus Homecare's stock. Their forecasts range from $75.00 to $115.00. On average, they anticipate Addus Homecare's stock price to reach $89.8333 in the next twelve months. This suggests a possible upside of 10.4% from the stock's current price. View Analyst Price Targets for Addus Homecare.
What is the consensus analysts' recommendation for Addus Homecare?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Addus Homecare in the last year. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Addus Homecare.
Has Addus Homecare been receiving favorable news coverage?
News articles about ADUS stock have trended negative this week, according to InfoTrie. The research firm identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Addus Homecare earned a coverage optimism score of -2.9 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for Addus Homecare.
Who are some of Addus Homecare's key competitors?
What other stocks do shareholders of Addus Homecare own?
Who are Addus Homecare's key executives?
Addus Homecare's management team includes the folowing people:
- Mr. R. Dirk Allison, CEO, Pres & Director (Age 63)
- Mr. Brian W. Poff, CFO, Exec. VP, Sec. & Treasurer (Age 45)
- Mr. W. Bradley Bickham, COO & Exec. VP (Age 56)
- Mr. James Zoccoli, Exec. VP & Chief Information Officer (Age 62)
- Mr. Darby Anderson, Exec. VP & Chief Devel. Officer (Age 53)
Who are Addus Homecare's major shareholders?
Addus Homecare's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Eos Management L.P. (13.14%), BlackRock Inc. (11.74%), TimesSquare Capital Management LLC (6.97%), Vanguard Group Inc. (5.13%), Price T Rowe Associates Inc. MD (3.49%) and Invesco Ltd. (2.50%). Company insiders that own Addus Homecare stock include Brian Poff, Darby Anderson, Eos Capital Partners Iii L P, James Zoccoli, Laurie Manning, Mark L First, R Dirk Allison and W Bradley Bickham. View Institutional Ownership Trends for Addus Homecare.
Which institutional investors are selling Addus Homecare stock?
ADUS stock was sold by a variety of institutional investors in the last quarter, including Eos Management L.P., AQR Capital Management LLC, Renaissance Technologies LLC, Vanguard Group Inc., Panagora Asset Management Inc., Sawgrass Asset Management LLC, Advisor Group Inc. and WCM Investment Management LLC. Company insiders that have sold Addus Homecare company stock in the last year include Brian Poff, Darby Anderson, Eos Capital Partners Iii L P, James Zoccoli, Laurie Manning, Mark L First, R Dirk Allison and W Bradley Bickham. View Insider Buying and Selling for Addus Homecare.
Which institutional investors are buying Addus Homecare stock?
ADUS stock was bought by a variety of institutional investors in the last quarter, including Invesco Ltd., Emerald Advisers LLC, Emerald Mutual Fund Advisers Trust, Marshall Wace LLP, Castleark Management LLC, Point72 Asset Management L.P., Calamos Advisors LLC and BlackRock Inc.. View Insider Buying and Selling for Addus Homecare.
How do I buy shares of Addus Homecare?
Shares of ADUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Addus Homecare's stock price today?
One share of ADUS stock can currently be purchased for approximately $81.39.
How big of a company is Addus Homecare?
Addus Homecare has a market capitalization of $1.25 billion and generates $518.12 million in revenue each year. The company earns $17.50 million in net income (profit) each year or $1.69 on an earnings per share basis. Addus Homecare employs 33,153 workers across the globe.View Additional Information About Addus Homecare.
What is Addus Homecare's official website?
How can I contact Addus Homecare?
Addus Homecare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The company can be reached via phone at 469-535-8200 or via email at [email protected]
MarketBeat Community Rating for Addus Homecare (NASDAQ ADUS)
MarketBeat's community ratings are surveys of what our community members think about Addus Homecare and other stocks. Vote "Outperform" if you believe ADUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ADUS will underperform the S&P 500 over the long term. You may vote once every thirty days.
